Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 125 | 2024 | 3762 | 20.940 |
Why?
|
Rheumatic Diseases | 46 | 2024 | 664 | 9.020 |
Why?
|
Lung Diseases, Interstitial | 31 | 2024 | 935 | 8.550 |
Why?
|
Antirheumatic Agents | 43 | 2024 | 1374 | 8.180 |
Why?
|
Rheumatology | 23 | 2024 | 619 | 4.340 |
Why?
|
Autoimmune Diseases | 16 | 2024 | 2260 | 2.520 |
Why?
|
Smoking | 24 | 2024 | 9099 | 2.260 |
Why?
|
Bronchiectasis | 3 | 2024 | 139 | 2.220 |
Why?
|
Methotrexate | 14 | 2024 | 1722 | 2.190 |
Why?
|
Lupus Erythematosus, Systemic | 22 | 2024 | 2173 | 1.760 |
Why?
|
Hydroxychloroquine | 11 | 2021 | 427 | 1.760 |
Why?
|
Rheumatoid Factor | 8 | 2023 | 184 | 1.760 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 9 | 2024 | 3246 | 1.720 |
Why?
|
Arthritis, Psoriatic | 5 | 2023 | 220 | 1.540 |
Why?
|
Nurses | 17 | 2024 | 2494 | 1.310 |
Why?
|
Risk Factors | 78 | 2025 | 74915 | 1.290 |
Why?
|
Biological Products | 8 | 2024 | 937 | 1.220 |
Why?
|
Autoantibodies | 14 | 2024 | 2131 | 1.140 |
Why?
|
Women's Health | 4 | 2021 | 2079 | 1.130 |
Why?
|
Sarcoidosis | 3 | 2019 | 539 | 1.120 |
Why?
|
Humans | 239 | 2025 | 768369 | 1.100 |
Why?
|
Health Behavior | 5 | 2022 | 2649 | 1.100 |
Why?
|
Tobacco Smoke Pollution | 3 | 2021 | 828 | 1.060 |
Why?
|
Asthma | 8 | 2023 | 6274 | 1.050 |
Why?
|
Autoimmunity | 4 | 2024 | 1361 | 1.040 |
Why?
|
Middle Aged | 117 | 2025 | 223406 | 1.030 |
Why?
|
Arthritis | 3 | 2024 | 685 | 0.990 |
Why?
|
Risk Reduction Behavior | 4 | 2021 | 1120 | 0.980 |
Why?
|
Air Pollution | 3 | 2024 | 2364 | 0.930 |
Why?
|
Lung Transplantation | 2 | 2024 | 1310 | 0.930 |
Why?
|
Incidence | 33 | 2024 | 21552 | 0.930 |
Why?
|
Sinusitis | 3 | 2024 | 995 | 0.920 |
Why?
|
Glucocorticoids | 12 | 2024 | 2170 | 0.900 |
Why?
|
Female | 137 | 2025 | 396926 | 0.900 |
Why?
|
Disease Progression | 13 | 2024 | 13643 | 0.900 |
Why?
|
Spirometry | 2 | 2024 | 928 | 0.880 |
Why?
|
Prospective Studies | 47 | 2025 | 54913 | 0.850 |
Why?
|
Bone Diseases | 2 | 2019 | 418 | 0.850 |
Why?
|
Case-Control Studies | 26 | 2024 | 22286 | 0.820 |
Why?
|
Gout | 4 | 2022 | 621 | 0.790 |
Why?
|
Adult | 87 | 2025 | 223528 | 0.740 |
Why?
|
Male | 96 | 2025 | 364761 | 0.720 |
Why?
|
Antigens, Viral | 1 | 2024 | 992 | 0.700 |
Why?
|
Patient Education as Topic | 4 | 2019 | 2339 | 0.690 |
Why?
|
Smoking Cessation | 4 | 2019 | 2078 | 0.670 |
Why?
|
Air Pollutants | 3 | 2024 | 2905 | 0.660 |
Why?
|
Psoriasis | 3 | 2023 | 947 | 0.660 |
Why?
|
Antimalarials | 3 | 2020 | 910 | 0.650 |
Why?
|
Pulmonary Emphysema | 1 | 2024 | 690 | 0.640 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.640 |
Why?
|
Early Diagnosis | 1 | 2024 | 1196 | 0.630 |
Why?
|
Mucin-5B | 4 | 2023 | 148 | 0.620 |
Why?
|
Aged | 57 | 2025 | 171514 | 0.610 |
Why?
|
Risk Assessment | 23 | 2024 | 24310 | 0.600 |
Why?
|
Climate Change | 1 | 2024 | 508 | 0.580 |
Why?
|
Life Style | 6 | 2022 | 3929 | 0.570 |
Why?
|
Gastrointestinal Agents | 1 | 2021 | 510 | 0.550 |
Why?
|
Environmental Exposure | 5 | 2024 | 4533 | 0.550 |
Why?
|
Pneumonia | 2 | 2020 | 2162 | 0.540 |
Why?
|
Antiviral Agents | 4 | 2024 | 3062 | 0.540 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 190 | 0.540 |
Why?
|
Public Opinion | 1 | 2020 | 487 | 0.530 |
Why?
|
Peptides, Cyclic | 4 | 2022 | 393 | 0.530 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 439 | 0.530 |
Why?
|
Sulfasalazine | 1 | 2016 | 85 | 0.520 |
Why?
|
Coronavirus Infections | 8 | 2021 | 3116 | 0.520 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4213 | 0.510 |
Why?
|
Lung | 11 | 2024 | 10090 | 0.510 |
Why?
|
Seafood | 1 | 2019 | 395 | 0.500 |
Why?
|
Drug Monitoring | 1 | 2021 | 964 | 0.500 |
Why?
|
Fusarium | 1 | 2015 | 51 | 0.500 |
Why?
|
Diet | 7 | 2024 | 8098 | 0.500 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 4049 | 0.500 |
Why?
|
Gastritis | 1 | 2017 | 200 | 0.490 |
Why?
|
Bariatric Surgery | 3 | 2020 | 1007 | 0.480 |
Why?
|
Health Education | 2 | 2018 | 1059 | 0.480 |
Why?
|
Granuloma | 1 | 2017 | 331 | 0.480 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 354 | 0.470 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3240 | 0.460 |
Why?
|
Family | 2 | 2016 | 3208 | 0.460 |
Why?
|
Registries | 11 | 2023 | 8372 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1795 | 0.420 |
Why?
|
Vital Capacity | 3 | 2024 | 984 | 0.420 |
Why?
|
Antibodies, Antinuclear | 5 | 2024 | 343 | 0.420 |
Why?
|
Sex Factors | 8 | 2025 | 10647 | 0.400 |
Why?
|
United States | 33 | 2025 | 73120 | 0.390 |
Why?
|
Time Factors | 18 | 2024 | 40271 | 0.390 |
Why?
|
Vaccination | 12 | 2024 | 3433 | 0.390 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15638 | 0.390 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 347 | 0.390 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12561 | 0.380 |
Why?
|
Myositis | 3 | 2024 | 278 | 0.380 |
Why?
|
Cohort Studies | 23 | 2025 | 41782 | 0.370 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1468 | 0.370 |
Why?
|
Respiratory Function Tests | 5 | 2024 | 1697 | 0.360 |
Why?
|
Retrospective Studies | 18 | 2024 | 81835 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 18047 | 0.350 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15965 | 0.330 |
Why?
|
Exercise | 4 | 2022 | 5940 | 0.330 |
Why?
|
Logistic Models | 9 | 2022 | 13323 | 0.330 |
Why?
|
Lung Diseases | 1 | 2019 | 1926 | 0.320 |
Why?
|
Connective Tissue Diseases | 3 | 2024 | 285 | 0.320 |
Why?
|
Obesity | 6 | 2020 | 13065 | 0.310 |
Why?
|
Environment | 1 | 2014 | 1126 | 0.300 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2018 | 1398 | 0.300 |
Why?
|
Serologic Tests | 2 | 2021 | 383 | 0.300 |
Why?
|
Physicians | 2 | 2023 | 4615 | 0.300 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2019 | 64 | 0.290 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9261 | 0.290 |
Why?
|
Prednisone | 5 | 2023 | 1568 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2291 | 0.290 |
Why?
|
Body Weight | 1 | 2017 | 4630 | 0.280 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 601 | 0.270 |
Why?
|
Neoplasms | 5 | 2024 | 22389 | 0.270 |
Why?
|
Body Mass Index | 9 | 2021 | 13030 | 0.260 |
Why?
|
Prevalence | 6 | 2023 | 15879 | 0.260 |
Why?
|
Immunologic Factors | 3 | 2024 | 1600 | 0.260 |
Why?
|
Inflammation | 6 | 2024 | 10863 | 0.250 |
Why?
|
Pandemics | 10 | 2023 | 8751 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13589 | 0.240 |
Why?
|
Risk | 4 | 2021 | 9642 | 0.240 |
Why?
|
Double-Blind Method | 6 | 2021 | 12450 | 0.230 |
Why?
|
Scleroderma, Systemic | 3 | 2024 | 349 | 0.230 |
Why?
|
Research Design | 4 | 2022 | 6217 | 0.230 |
Why?
|
Remission Induction | 3 | 2021 | 2408 | 0.220 |
Why?
|
Bone and Bones | 1 | 2014 | 2589 | 0.220 |
Why?
|
Antibodies, Viral | 6 | 2024 | 3210 | 0.220 |
Why?
|
Age Factors | 7 | 2020 | 18477 | 0.220 |
Why?
|
I-kappa B Kinase | 1 | 2024 | 250 | 0.210 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 233 | 0.210 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 233 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1852 | 0.210 |
Why?
|
Odds Ratio | 6 | 2022 | 9687 | 0.200 |
Why?
|
Folic Acid | 2 | 2021 | 1336 | 0.200 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 155 | 0.200 |
Why?
|
Influenza, Human | 1 | 2013 | 1540 | 0.200 |
Why?
|
Forced Expiratory Volume | 2 | 2024 | 1820 | 0.200 |
Why?
|
Receptors, Interleukin-6 | 1 | 2023 | 224 | 0.190 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 126 | 0.190 |
Why?
|
Alanine | 1 | 2024 | 613 | 0.190 |
Why?
|
Oral Health | 2 | 2019 | 494 | 0.190 |
Why?
|
Hospitalization | 8 | 2022 | 10845 | 0.190 |
Why?
|
Comorbidity | 8 | 2024 | 10601 | 0.180 |
Why?
|
Depression | 1 | 2021 | 8235 | 0.180 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 304 | 0.180 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5803 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2279 | 0.180 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 218 | 0.180 |
Why?
|
Interleukin-12 | 1 | 2023 | 578 | 0.170 |
Why?
|
Alcohol Drinking | 3 | 2020 | 4052 | 0.170 |
Why?
|
Emphysema | 1 | 2022 | 238 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2023 | 65408 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 559 | 0.170 |
Why?
|
Premature Birth | 2 | 2023 | 1816 | 0.170 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 868 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 612 | 0.160 |
Why?
|
Postmenopause | 2 | 2018 | 2519 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2022 | 556 | 0.160 |
Why?
|
Health Surveys | 3 | 2019 | 4056 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 16023 | 0.150 |
Why?
|
Nutritive Value | 1 | 2021 | 349 | 0.150 |
Why?
|
Immunocompromised Host | 2 | 2020 | 865 | 0.150 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4285 | 0.150 |
Why?
|
Area Under Curve | 3 | 2021 | 1640 | 0.150 |
Why?
|
Diet Surveys | 2 | 2021 | 1161 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1727 | 0.150 |
Why?
|
Granzymes | 1 | 2019 | 278 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 937 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2022 | 59679 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 435 | 0.150 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12096 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 13025 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 520 | 0.140 |
Why?
|
Occupational Therapy | 1 | 2019 | 142 | 0.140 |
Why?
|
Respiration, Artificial | 4 | 2022 | 2723 | 0.140 |
Why?
|
Mass Media | 1 | 2020 | 304 | 0.140 |
Why?
|
Demography | 1 | 2022 | 1643 | 0.140 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39429 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 375 | 0.140 |
Why?
|
Medical History Taking | 1 | 2021 | 776 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6320 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12771 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1382 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 595 | 0.140 |
Why?
|
Interinstitutional Relations | 1 | 2018 | 236 | 0.140 |
Why?
|
Citrulline | 1 | 2016 | 107 | 0.130 |
Why?
|
Military Medicine | 1 | 2018 | 185 | 0.130 |
Why?
|
Metabolome | 2 | 2020 | 1009 | 0.130 |
Why?
|
Life Change Events | 1 | 2021 | 964 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 599 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2022 | 848 | 0.130 |
Why?
|
Chemokines | 1 | 2020 | 963 | 0.130 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 783 | 0.130 |
Why?
|
Epidemiologic Studies | 1 | 2019 | 681 | 0.130 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2531 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 804 | 0.130 |
Why?
|
Phosphoproteins | 1 | 2024 | 2450 | 0.130 |
Why?
|
Rheumatic Fever | 1 | 2015 | 73 | 0.120 |
Why?
|
Osteonecrosis | 1 | 2017 | 230 | 0.120 |
Why?
|
Communication | 2 | 2020 | 3910 | 0.120 |
Why?
|
Needs Assessment | 2 | 2019 | 1146 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 533 | 0.120 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2018 | 304 | 0.120 |
Why?
|
Prognosis | 3 | 2021 | 30031 | 0.120 |
Why?
|
HLA Antigens | 1 | 2020 | 1333 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 552 | 0.120 |
Why?
|
Arginine | 1 | 2018 | 923 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 836 | 0.120 |
Why?
|
Complementary Therapies | 1 | 2019 | 487 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 64 | 0.120 |
Why?
|
Military Personnel | 2 | 2021 | 1264 | 0.120 |
Why?
|
Electronic Health Records | 2 | 2024 | 4877 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 893 | 0.120 |
Why?
|
Algorithms | 3 | 2020 | 14157 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.110 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 469 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2017 | 603 | 0.110 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 655 | 0.110 |
Why?
|
Amino Acids | 2 | 2021 | 1713 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3463 | 0.110 |
Why?
|
Carotenoids | 1 | 2017 | 621 | 0.110 |
Why?
|
Epitopes | 2 | 2017 | 2523 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14766 | 0.110 |
Why?
|
Young Adult | 10 | 2024 | 60038 | 0.110 |
Why?
|
Fibrosis | 1 | 2021 | 2076 | 0.110 |
Why?
|
Endosonography | 1 | 2017 | 622 | 0.110 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 150 | 0.110 |
Why?
|
Overweight | 2 | 2014 | 2428 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 756 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 591 | 0.110 |
Why?
|
Spondylitis, Ankylosing | 1 | 2014 | 160 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2226 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4613 | 0.100 |
Why?
|
Antibody Formation | 3 | 2023 | 1393 | 0.100 |
Why?
|
Physical Examination | 1 | 2019 | 1262 | 0.100 |
Why?
|
Particulate Matter | 1 | 2024 | 2614 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 243 | 0.100 |
Why?
|
Mentors | 1 | 2018 | 672 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20763 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2024 | 3076 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 683 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4132 | 0.100 |
Why?
|
Rare Diseases | 1 | 2017 | 630 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3342 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1138 | 0.100 |
Why?
|
Weight Gain | 2 | 2022 | 2357 | 0.090 |
Why?
|
Cytokines | 3 | 2022 | 7440 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 749 | 0.090 |
Why?
|
Gastrectomy | 1 | 2015 | 696 | 0.090 |
Why?
|
Alleles | 4 | 2024 | 6880 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2258 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3727 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26348 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1172 | 0.090 |
Why?
|
Health Communication | 1 | 2013 | 216 | 0.080 |
Why?
|
China | 3 | 2020 | 2397 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1158 | 0.080 |
Why?
|
Menopause | 1 | 2017 | 1650 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1100 | 0.080 |
Why?
|
Immunophenotyping | 2 | 2024 | 1868 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1214 | 0.080 |
Why?
|
Chloroquine | 2 | 2020 | 275 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7064 | 0.080 |
Why?
|
Azithromycin | 2 | 2020 | 200 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6549 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2021 | 2913 | 0.080 |
Why?
|
Phenotype | 3 | 2017 | 16712 | 0.080 |
Why?
|
Survival Analysis | 2 | 2017 | 10127 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 2034 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6537 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3854 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11928 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2834 | 0.070 |
Why?
|
Patient Care Team | 1 | 2019 | 2526 | 0.070 |
Why?
|
Disease | 1 | 2013 | 672 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 829 | 0.070 |
Why?
|
Societies, Medical | 3 | 2024 | 3954 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1892 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2444 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8510 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10269 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2513 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2019 | 3629 | 0.060 |
Why?
|
Genetic Variation | 2 | 2024 | 6607 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2411 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1912 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5426 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18390 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1816 | 0.060 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2023 | 925 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5740 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 89163 | 0.060 |
Why?
|
Weight Loss | 1 | 2015 | 2710 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.060 |
Why?
|
Food Handling | 1 | 2024 | 158 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2056 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7863 | 0.060 |
Why?
|
Child | 4 | 2023 | 80856 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7467 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9359 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3431 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2023 | 191 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6816 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2024 | 242 | 0.050 |
Why?
|
Ireland | 1 | 2022 | 170 | 0.050 |
Why?
|
Fast Foods | 1 | 2024 | 216 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3837 | 0.050 |
Why?
|
Models, Structural | 1 | 2022 | 340 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 330 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 327 | 0.050 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 116 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2023 | 393 | 0.050 |
Why?
|
Fabaceae | 1 | 2021 | 104 | 0.050 |
Why?
|
Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
Xenobiotics | 1 | 2021 | 71 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 52 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4779 | 0.050 |
Why?
|
Spermidine | 1 | 2020 | 62 | 0.050 |
Why?
|
Spondylarthropathies | 1 | 2020 | 14 | 0.040 |
Why?
|
Databases, Factual | 3 | 2021 | 8081 | 0.040 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 131 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 631 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2024 | 507 | 0.040 |
Why?
|
Caprylates | 1 | 2020 | 115 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 539 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4362 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36840 | 0.040 |
Why?
|
Azetidines | 1 | 2020 | 143 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 254 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2024 | 734 | 0.040 |
Why?
|
Nuts | 1 | 2021 | 265 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.040 |
Why?
|
Translations | 1 | 2019 | 82 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2018 | 187 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 98 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 536 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 733 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5880 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 483 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 977 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5455 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4728 | 0.040 |
Why?
|
Methionine | 1 | 2020 | 574 | 0.040 |
Why?
|
Diet Records | 1 | 2019 | 427 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20232 | 0.040 |
Why?
|
Transaminases | 1 | 2018 | 199 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11515 | 0.040 |
Why?
|
Interleukins | 1 | 2022 | 791 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 555 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 942 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8905 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2023 | 26394 | 0.040 |
Why?
|
Purines | 1 | 2020 | 614 | 0.040 |
Why?
|
Self Report | 2 | 2022 | 3771 | 0.040 |
Why?
|
DNA | 2 | 2021 | 7213 | 0.030 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
Beer | 1 | 2017 | 135 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 321 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1970 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 576 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 935 | 0.030 |
Why?
|
Wine | 1 | 2017 | 172 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1786 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6347 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 672 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1556 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1184 | 0.030 |
Why?
|
Piperidines | 1 | 2024 | 1664 | 0.030 |
Why?
|
Vasculitis | 1 | 2020 | 524 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2103 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1841 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2491 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2019 | 639 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 30179 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1668 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14725 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4582 | 0.030 |
Why?
|
Placebo Effect | 1 | 2018 | 518 | 0.030 |
Why?
|
Menarche | 1 | 2017 | 538 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 747 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2015 | 319 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1891 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3623 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2932 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2861 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1915 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1021 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3050 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3708 | 0.020 |
Why?
|
Medical Informatics | 1 | 2019 | 737 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1296 | 0.020 |
Why?
|
Fear | 1 | 2020 | 1494 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3374 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3207 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7245 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2010 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1813 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1988 | 0.020 |
Why?
|
Genomics | 2 | 2020 | 5912 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1070 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1514 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2024 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 798 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1892 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1343 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2959 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2723 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2292 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12813 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3234 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9379 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 3115 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2141 | 0.020 |
Why?
|
Animals | 3 | 2024 | 169424 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 19035 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13045 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3442 | 0.020 |
Why?
|
Mice | 2 | 2024 | 82051 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3778 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14483 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8537 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6880 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22365 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30235 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36496 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9790 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12242 | 0.010 |
Why?
|